EDGAR Filing Documents for 0001144204-16-096398

Form 8-K - Current report:

SEC Accession No. 0001144204-16-096398

Filing Date

2016-04-26

Accepted

2016-04-26 17:14:47

Documents

Period of Report

2016-04-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v437968_8k.htm	8-K	57667
2	ESCROW AGREEMENT	v437968_ex10-1.htm	EX-10.1	69625
3	REGISTRATION RIGHTS AGREEMENT	v437968_ex10-2.htm	EX-10.2	131189
4	EMPLOYMENT AGREEMENT	v437968_ex10-3.htm	EX-10.3	78458
5	EMPLOYMENT AGREEMENT	v437968_ex10-4.htm	EX-10.4	71007
	Complete submission text file	0001144204-16-096398.txt		409730

Mailing Address 483 BAY STREET N105 TORONTO A6 M5G2C9

Business Address 483 BAY STREET N105 TORONTO A6 M5G2C9 1.416.640.7887

Bionik Laboratories Corp. (Filer) CIK: 0001508381 (see all company filings)